Hedge Funds Bought Navistar And These Other Stocks

Page 1 of 2

CITADEL INVESTMENT GROUP13F filings are a very complete picture of what a hedge fund has been doing, but unfortunately they are only released six to seven weeks after the end of a quarter. 13D and 13G filings, while generally restricted to smaller-cap stocks, are much more up to date and therefore allow investors to know that a certain hedge fund manager has been buying a specific stock in the past week or two (in order to bring the fund above a 5% ownership threshold, or to add more shares from what had been previously reported in a filing). The investor in question can then examine these stocks more closely to see if it makes sense to purchase them. Here are five stocks that hedge funds have recently reported buying:

Billionaire Ken Griffin and his team at Citadel Investment Group reported owning 4.3 million shares of truck and engine manufacturer Navistar International Corp (NYSE:NAV), which has been a target of billionaire activist investor Carl Icahn. Citadel had owned less than 600,000 shares at the beginning of October according to the fund’s 13F filing (see more stocks the fund owned). The company has been taking large losses, and is expected to be unprofitable in the current fiscal year (ending in October 2013) as well. After that point Wall Street analysts see Navistar’s fortunes improving, with a forward price-to-earnings multiple of 11. However, we think that the company is still too far out from positive earnings to be worth considering as a value investment.

According to a 13G filed with the SEC, Michael Johnston’s Steelhead Partners (find more stocks Steelhead likes) owns 4.1 million shares of Photronics, Inc. (NASDAQ:PLAB), which comes out to 6.4% of the total shares outstanding. Photronics is a provider of photomasks which are in turn used by producers of semiconductors and flat panel displays. Revenue was down 15% in its most recent fiscal quarter compared to the same period in the previous fiscal year, and earnings dropped 59%. 11% of the outstanding shares are held short, though the trailing P/E multiple of 14 suggests that the stock has some upside potential if the company can end its declining performance.

Steelhead Partners also now owns 2.7 million shares of development-stage biotechnology company Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN). The 13G filed with the SEC has the fund owning 5.8% of the total shares outstanding; Steelhead had owned some of Enzon’s debt in its most recent 13F filing, but did not report any equity ownership. The company’s products in development primarily consist of treatments for cancer patients. The stock is down 32% over the last year, though in its most recent quarterly report Enzon held a large cash position and so the downside from this point may be limited.

See two stock picks from Chuck Royce:

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!